AVTECH showed solid growth at 33% y/y, meeting Redeye Research estimates (RRe), driven by new contracts, though EBITDA missed by 4% from higher OPEX. The robust 1,400 aircraft pipeline worth up to SEK72m and quadrupling sales staff signals a compelling long-term growth story. New deals, potentially landing this spring, are the key catalyst. Redeye raised long-term sales estimates while raising OPEX for 2025.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/